Connect with us

Published

on

President-elect Donald Trumps choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace celebrity doctor Mehmet Oz recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Use Our Content

It can be republished for free.

Ozs holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000, as well as shares of pharmaceutical firms and tech companies with business in the health care sector, such as Amazon. Collectively, Ozs investments total tens of millions of dollars, according to financial disclosures he filed during his failed 2022 run for a Pennsylvania U.S. Senate seat.

Trump said Tuesday he would nominate Oz as administrator of the Centers for Medicare & Medicaid Services. The agencys scope is huge: CMS oversees coverage for more than 160 million Americans, nearly half the population. Medicare alone accounts for approximately $1 trillion in annual spending, with over 67 million enrollees.

UnitedHealth Group is one of the largest health care companies in the nation and arguably the most important business partner of CMS, through which it is the leading provider of commercial health plans available to Medicare beneficiaries.

UnitedHealth also offers managed-care plans under Medicaid, the joint state-federal program for low-income people, and sells plans on government-run marketplaces set up via the Affordable Care Act. Oz also had smaller stakes in CVS Health, which now includes the insurer Aetna, and in the insurer Cigna. Email Sign-Up

Subscribe to KFF Health News' free Weekly Edition. Your Email Address Sign Up

It’s not clear if Oz, a heart surgeon by training, still holds investments in health care companies, or if he would divest his shares or otherwise seek to mitigate conflicts of interest should he be confirmed by the Senate. Reached by phone on Wednesday, he said he was in a Zoom meeting and declined to comment. An assistant did not reply to an email message with detailed questions.

Its obvious that over the years hes cultivated an interest in the pharmaceutical industry and the insurance industry, said Peter Lurie, president of the Center for Science in the Public Interest, a watchdog group. That raises a question of whether he can be trusted to act on behalf of the American people. (The publisher of KFF Health News, David Rousseau, is on the CSPI board.)

Oz used his TikTok page on multiple occasions in November to praise Trump and Robert F. Kennedy Jr., including their efforts to take on the illness-industrial complex, and he slammed so-called experts like the big medical societies for dishing out what he called bad nutritional advice. Ozs positions on health policy have been chameleonic; in 2010, he cut an ad urging Californians to sign up for insurance under President Barack Obamas Affordable Care Act, telling viewers they had a historic opportunity.

Ozs 2022 financial disclosures show that the television star invested a substantial part of his wealth in health care and food firms. Were he confirmed to run CMS, his job would involve interacting with giants of the industry that have contributed to his wealth.

Given the breadth of his investments, it would be difficult for Oz to recuse himself from matters affecting his assets, if he still holds them. He could spend his time in a rocking chair if that happened, Lurie said.

In the past, nominees for government positions with similar potential conflicts of interest have chosen to sell the assets or otherwise divest themselves. For instance, Treasury Secretary Janet Yellen and Attorney General Merrick Garland agreed to divest their holdings in relevant, publicly traded companies when they joined the Biden administration.

Trump, however, declined in his first term to relinquish control of his own companies and other assets while in office, and he isnt expected to do so in his second term. He has not publicly indicated concern about his subordinates financial holdings.

CMS main job is to administer Medicare. About half of new enrollees now choose Medicare Advantage, in which commercial insurers provide their health coverage, instead of the traditional, government-run program, according to an analysis from KFF, a health information nonprofit that includes KFF Health News.

Proponents of Medicare Advantage say the private plans offer more compelling services than the government and better manage the costs of care. Critics note that Medicare Advantage plans have a long history of costing taxpayers more than the traditional program.

UnitedHealth, CVS, and Cigna are all substantial players in the Medicare Advantage market. Its not always a good relationship with the government. The Department of Justice filed a 2017 complaint against UnitedHealth alleging the company used false information to inflate charges to the government. The case is ongoing.

Oz is an enthusiastic proponent of Medicare Advantage. In 2020, he proposed offering Medicare Advantage to all; during his Senate run, he offered a more general pledge to expand those plans. After Trump announced Ozs nomination for CMS, Jeffrey Singer, a senior fellow at the libertarian-leaning Cato Institute, said he was uncertain about Dr. Ozs familiarity with health care financing and economics.

Singer said Ozs Medicare Advantage proposal could require large new taxes perhaps a 20% payroll tax to implement.

Oz has gotten a mixed reception from elsewhere in Washington. Pennsylvania Sen. John Fetterman, the Democrat who defeated Oz in 2022, signaled hed potentially support his appointment to CMS. If Dr. Oz is about protecting and preserving Medicare and Medicaid, Im voting for the dude, he said on the social platform X.

Ozs investments in companies doing business with the federal government dont end with big insurers. He and his family also hold hospital stocks, according to his 2022 disclosure, as well as a stake in Amazon worth as much as nearly $2.4 million. (Candidates for federal office are required to disclose a broad range of values for their holdings, not a specific figure.)

Amazon operates an internet pharmacy, and the company announced in June that its subscription service is available to Medicare enrollees. It also owns a primary care service, One Medical, that accepts Medicare and select Medicare Advantage plans.

Oz was also directly invested in several large pharmaceutical companies and, through investments in venture capital funds, indirectly invested in other biotech and vaccine firms. Big Pharma has been a frequent target of criticism and sometimes conspiracy theories from Trump and his allies. Kennedy, whom Trump has said hell nominate to be Health and Human Services secretary, is a longtime anti-vaccine activist.

During the Biden administration, Congress gave Medicare authority to negotiate with drug companies over their prices. CMS initially selected 10 drugs. Those drugs collectively accounted for $50.5 billion in spending between June 1, 2022, and May 31, 2023, under Medicares Part D prescription drug benefit.

At least four of those 10 medications are manufactured by companies in which Oz held stock, worth as much as about $50,000.

Oz may gain or lose financially from other Trump administration proposals.

For example, as of 2022, Oz held investments worth as much as $6 million in fertility treatment providers. To counter fears that politicians who oppose abortion would ban in vitro fertilization, Trump floated during his campaign making in vitro fertilization treatment free. Its unclear whether the government would pay for the services.

In his TikTok videos from earlier in November, Oz echoed attacks on the food industry by Kennedy and other figures in his Make America Healthy Again movement. They blame processed foods and underregulation of the industry for the poor health of many Americans, concerns shared by many Democrats and more mainstream experts.

But in 2022, Oz owned stakes worthas much as $80,000 in Dominos Pizza, Pepsi, and US Foods, as well as more substantial investments in other parts of the food chain, including cattle; Oz reported investments worth as much as $5.5 million in a farm and livestock, as well as a stake in a dairy-free milk startup. He was also indirectly invested in the restaurant chain Epic Burger.

One of his largest investments was in the Pennsylvania-based convenience store chain Wawa, which sells fast food and all manner of ultra-processed snacks. Oz and his wife reported a stake in the company, beloved by many Pennsylvanians, worth as much as $30 million.

Darius Tahir: DariusT@kff.org, @dariustahir Related Topics Elections Health Industry Insurance Medicare CMS Medicare Advantage Pennsylvania Trump Administration Contact Us Submit a Story Tip

Continue Reading

Business

Former Centrica chief Laidlaw in frame to chair embattled BP

Published

on

By

Former Centrica chief Laidlaw in frame to chair embattled BP

Sam Laidlaw, the former boss of Centrica, is among the candidates being considered as the next chairman of BP, Britain’s besieged oil and gas exploration giant.

Sky News has learnt that Mr Laidlaw is being considered by BP board members as a potential successor to Helge Lund, who announced in April that he would step down.

BP’s chair search comes with the £62bn oil major in a state of crisis, as industry predators circle and the pace of its strategic transformation being interrogated by shareholders.

Elliott Management, the activist investor, snapped up a multibillion pound stake in BP earlier this year and is pushing its chief executive, Murray Auchincloss, to accelerate spending cuts and ditch a string of renewable energy commitments.

Mr Lund’s departure will come after nearly a quarter of BP’s shareholders opposed his re-election at its annual meeting in April – an unusually large protest given that his intention to step down had already been announced.

BP’s senior independent director – the Aviva chief executive Amanda Blanc – is said to be moving “at pace” to complete the recruitment process.

A number of prominent candidates are understood to be in discussions with headhunters advising BP on the search.

More from Money

Mr Laidlaw would be a logical choice to take the role, having transformed Centrica, the owner of British Gas, during his tenure, which ended in 2014.

Since then, he has had a long stint – which recently concluded – on the board of miner Rio Tinto, which has been fending off activist calls to abandon its London listing.

He also established, and then sold, Neptune Energy, an oil company which was acquired by Italy’s Eni for nearly £4bn in 2023.

Last December, Mr Laidlaw was appointed chairman of AWE, the government-owned body which oversees Britain’s nuclear weapons capability.

He also has strong family connections to BP, with his father, Christopher Laidlaw, having served as its deputy chairman during a long business career.

One person close to BP said the younger Mr Laidlaw had been approached about chairing the company during its previous recruitment process but had ruled himself out because of his Neptune Energy role.

The status of his engagement with BP’s search was unclear on Saturday.

Another person said to have been approached is Ken MacKenzie, who recently retired as chairman of the mining giant BHP.

Mr MacKenzie headed BHP during a period when Elliott held a stake in the company, and is said to have a good working relationship with the investor.

Shares in BP have continued their downward trajectory over the last year, having fallen by nearly a fifth during that period.

The company’s valuation slump is reported to have drawn renewed interest in a possible takeover bid, with rivals Shell and ExxonMobil among those said to have “run the numbers” in recent months.

Reports of such interest have not elicited any formal response, suggesting that any deal is conceptual at this stage.

BP is racing to sell assets including Castrol, its lubricants division, which could command a price of about $8bn.

This weekend, BP declined to comment, while Mr Laidlaw could not be reached for comment.

Continue Reading

Science

SpaceX Starship Rocket Explodes During Ground Test at Texas Launch Pad

Published

on

By

SpaceX Starship Rocket Explodes During Ground Test at Texas Launch Pad

An explosion rocked SpaceX’s Starbase facility in Texas late Wednesdaynight after a Starship rocket exploded on the test pad during a routine ground test. The blast occurred at about 11:00 pm (0400 GMT Thursday) and created a huge fireball in the sky, with no immediate reports of casualties. The test, intended as a so-called static fire of the Starship system, caused the total destruction of the entire vehicle and some damage to nearby infrastructure. A security cordon was already in place, and all staff were safe and accounted for during the security alert.

SpaceX Starship Explosion During Test Linked to Pressurized Tank Failure in Nosecone, Says Company

As per a statement issued by SpaceX, the explosion was caused by “a sudden energetic event” during preparations for a static fire involving the Super Heavy booster. Initial analysis suggests a pressurised tank, known as a COPV (Composite Overwrapped Pressure Vessel) in the rocket’s nosecone, may have failed, though a full investigation is underway. Officials clarified that there were “no commonalities” between the COPVs on Starship and those used in the Falcon series. Fires broke out following the explosion but were quickly contained as the area had been cleared of personnel.

Starship, the rocket that is 403 feet tall, is billed as the most powerful large launch vehicle built. Intended to lift up to 150 metric tonnes and return to Earth, the Starship is a central part of Elon Musk’s dream of building a human settlement on Mars. Musk downplayed the explosion, referring to it as a “scratch” in an official statement. The vehicle was preparing for what would have been its 10th test flight.

The latest failure is the latest in a series of high-profile setbacks for Starship, including a prototype that literally blew up over the Indian Ocean in May. On that mission, the rocket launched as planned, but its booster did not accomplish a planned splashdown. Previous tries also saw the upper stage breaking apart during mid-flight. Notably, despite its own trials and tribulations, SpaceX doubled down on its frenetic development tempo of “test aggressively and iterate quickly”.

In recent days, the Federal Aviation Administration approved a plan by the company to conduct up to 25 launches a year of such craft, turning aside environmental concerns cited by conservation groups. NASA, which uses another SpaceX project, the Dragon, to ferry astronauts to orbit, also continues to support Starship as another deep-space transportation system down the line, so the long-term plan appears to remain on track.

Continue Reading

Science

NASA Postpones Axiom Mission 4 Launch to Ensure Space Station Readiness After Repairs

Published

on

By

NASA Postpones Axiom Mission 4 Launch to Ensure Space Station Readiness After Repairs

NASA has postponed the launch to the International Space Station of an Axiom Space commercial crew mission, Axiom Mission 4 (Ax-4), that was planned to launch on or after June 22 to allow more time to assess the readiness of the station’s configuration. The station is undergoing inspections following recent repair operations on the end of the Zvezda service module. Because the station’s life support systems and other onboard subsystems are interrelated, NASA is scrutinising all available data, including these dates, as the agency considers a new target launch date to ensure that the station has some tasks to remain operable before beginning to support more crew.

NASA Delays Historic Axiom Mission 4 to Ensure ISS Systems Are Ready for International Crew

As per a NASA update, the decision to stand down was made as part of standard operations to validate the readiness of all systems onboard the ISS to accommodate additional crew. The Zvezda module on board, which is central to sustaining life and propulsion, had been recently serviced. Because the space station is such a conjoined system, the agency is being extra cautious, requiring more time than usual to pore over technical data before giving the mission a green light.

Former NASA astronaut Peggy Whitson is serving as Axiom’s Director of Human Spaceflight, leading the remarkably important orbital mission. She is part of the crew accompanying Indian Space Research Organisation (ISRO) astronaut Shubhanshu Shukla as pilot and two mission specialists – Sławosz Uznański-Wiśniewski (Poland) and Tibor Kapu (Hungary). It is a great operation in space, international co-operation, and it’s a great credit to all the countries involved.

While the astronauts remain in quarantine at NASA’s Kennedy Space Centre in Florida, SpaceX’s Falcon 9 rocket and Dragon spacecraft are reported to be in excellent condition at Launch Complex 39A and ready for flight whenever a new launch date is established. Postponing is a precaution, but one that underscores NASA’s prioritisation of crew safety and mission success.

NASA and its collaborators have stressed the symbolic and scientific significance of the mission — its effect on not only the nations involved but on the future of commercial space travel as well. A new date and time for launch will be determined once ongoing evaluations are complete on the station’s readiness to host the incoming crew.

Continue Reading

Trending